Advances and potential treatment for Philadelphia chromosome-positive adult acute lymphoid leukaemia.
about
Imatinib mesylate in the treatment of hematologic malignancies.Identification of a novel p190-derived breakpoint Peptide suitable for Peptide vaccine therapeutic approach in ph+ acute lymphoblastic leukemia patients.Efficacy of dasatinib in conjunction with alpha-interferon for the treatment of imatinib-resistant and dasatinib-resistant Ph+ acute lymphoblastic leukemia.
P2860
Advances and potential treatment for Philadelphia chromosome-positive adult acute lymphoid leukaemia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Advances and potential treatme ...... dult acute lymphoid leukaemia.
@ast
Advances and potential treatme ...... dult acute lymphoid leukaemia.
@en
type
label
Advances and potential treatme ...... dult acute lymphoid leukaemia.
@ast
Advances and potential treatme ...... dult acute lymphoid leukaemia.
@en
prefLabel
Advances and potential treatme ...... dult acute lymphoid leukaemia.
@ast
Advances and potential treatme ...... dult acute lymphoid leukaemia.
@en
P2860
P50
P1476
Advances and potential treatme ...... dult acute lymphoid leukaemia.
@en
P2093
Giuseppe Visani
Pier Paolo Piccaluga
P2860
P304
P356
10.1517/14712598.6.10.1011
P407
P577
2006-10-01T00:00:00Z